Medtronic Begins Prospective Trial Of Chronicle Remote Monitoring ICD
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's next-generation implantable cardioverter defibrillator (ICD) is a hybrid of two of the company's previously developed technologies
You may also be interested in...
FDA Panel To Review Medtronic’s Chronicle Heart Failure Monitor March 1
FDA's Circulatory System Devices Panel will consider Medtronic's PMA for the Chronicle continuous cardiac monitor for congestive heart failure patients at its March 1 meeting in Gaithersburg, Md
FDA Panel To Review Medtronic’s Chronicle Heart Failure Monitor March 1
FDA's Circulatory System Devices Panel will consider Medtronic's PMA for the Chronicle continuous cardiac monitor for congestive heart failure patients at its March 1 meeting in Gaithersburg, Md
Medtronic To Cardiologists: Get With The Guidelines On ICD Use
Medtronic's effort to reignite growth of the implantable cardioverter defibrillator market includes its IMPROVE HF study to evaluate physician practices and promote adoption of established guidelines for ICD use